Background: Mutations in p53 and ras genes are frequent in pancreatic carci
noma. Several ras mutations are consistently detected in the pancreatic jui
ce from patients with chronic pancreatitis. The p53 gene mutations have bee
n detected occasionally in chronic pancreatitis tissue. It was the aim of t
his study to evaluate the presence and clinical significance of p53 and ras
mutations in clinical pancreatic juice samples from patients with chronic
pancreatitis.
Methods: Pancreatic juice was obtained from 66 patients with chronic pancre
atitis and no evidence of pancreatic carcinoma (51 men, 15 women; age 17-86
years [mean 49.6 +/- 12.9]). Patients were followed prospectively for 26 /- 3 (4-54) months. Detection of p53 gene mutations was by temperature grad
ient gel electrophoresis (TGGE) and single strand conformation polymorphism
(SSCP) for exons 5-8. Analysis of ras mutations was performed by SSCP/poly
merase chain reaction, restriction fragment length polymorphism/polymerase
chain reaction. All mutations were confirmed by sequencing.
Results: Five of 66 (7.5%) pancreatic juice samples contained p53 mutations
, and ras mutations were detected in 6 cases (9%). Cytology was negative in
all cases. No pancreatic carcinoma developed during follow-up and neither
cancer cells nor preneoplastic lesions could be detected histologically in
resected specimens. Although no correlation between p53 mutations and durat
ion of pancreatitis or drinking habits was found, K-ras mutations correlate
d with both heavy smoking and severity of the disease.
Conclusion: p53 and ras mutations can be detected in a minority of pancreat
ic juice samples from patients with chronic pancreatitis in the absence of
malignancy.